This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jacob C. Frick, MD; Richard M. Hansen, MD; Tom Anderson, MD; Paul S. Ritch, MD

Arch Intern Med. 1986;146(4):791-792.

Abstract
• A patient with systemic recurrence of large-cell malignant lymphoma developed radiologic evidence of parenchymal brain metastasis. Treatment with systemic high-dose cytarabine resulted in complete regression of peripheral adenopathy and complete radiologic response in the central nervous system, with normalization of the brain computed tomographic scan. This case further demonstrates the ability of high-dose cytarabine to penetrate the blood-brain barrier and achieve therapeutic drug concentrations in the central nervous system, an area that might otherwise remain a pharmacologic sanctuary for tumor cells.

(Arch Intern Med 1986;146:791-792)

Author Affiliations
From the Section of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee.

Footnotes
Accepted for publication Nov 11, 1985.

Reprint requests to Box 133, 8700 W Wisconsin Ave, Milwaukee, WI 53226 (Dr Hansen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10
DeAngelis et al.
JCO 2002;20:4643-4648.
ABSTRACT | FULL TEXT  

The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: Cognitive function and performance status
O'Neill et al.
Neuro Oncol Duke 1999;1:196-203.
ABSTRACT